Share this
Amryt Pharma to Sell to Chiesi Farmaceutici in $1.48 Billion Cross-Border Transaction
January 9, 2023
Horizon Therapeutics to Be Acquired by Amgen for Approximately $28 Billion
December 12, 2022
DOJ Focusing Antitrust Scrutiny on the Boardroom: Is Your Board Ready?
Cooley Alert • November 2, 2022
Antitrust Lawsuit by FTC and 10 States Focuses on ‘Loyalty Programs’
Cooley Alert • October 18, 2022
Biotech Company ViaCyte to Be Acquired by Vertex Pharmaceuticals
July 13, 2022
Antitrust Trends to Look Out for in 2022
Cooley Alert • January 21, 2022
Arena Pharmaceuticals Agrees to Sell to Pfizer for $6.7 Billion
December 15, 2021
ThoughtSpot Brings Valuation to $4.2 Billion With Series F Round
November 22, 2021
NeoPhotonics Agrees to Sell to Lumentum for $918 Million
November 8, 2021
Virtual Reality Developer Within Agrees to Sell to Meta
November 5, 2021
Otsuka Enters Worldwide Collaboration Agreement With Sunovion and Sumitomo Dainippon Pharma
Companies to advance four promising Sunovion compounds that address serious neuropsychiatric disorders • October 13, 2021
Intersect ENT Agrees to Sell to Medtronic for More Than $1 Billion
August 17, 2021
Legal 500 US 2021 Highlights Cooley
July 19, 2021
IRL Reaches Unicorn Status With Series C Round
June 23, 2021
Snapdocs Valuation Climbs to Over $1.5 Billion With Series D Round
May 28, 2021
The Honest Company – $475 Million IPO
May 10, 2021
Gopuff More Than Doubles Valuation in Five Months With $1.15 Billion Funding Round
March 29, 2021
Five Prime Therapeutics Agrees to Sell to Amgen for $1.9 Billion
March 16, 2021
Horizon Therapeutics to Acquire Viela Bio to Grow Rare Disease Medicine Portfolio
February 5, 2021
10 Ways Antitrust Scrutiny Is Heating Up in 2021
Law360 • January 8, 2021
VelosBio Agrees to Sell to Merck for $2.75 Billion
November 9, 2020
goPuff Hits $3.9 Billion Valuation With Latest Funding Round
October 12, 2020
The No Kill Zone: The Other Side of Pharma Acquisitions
CPI Antitrust Chronicle • June 25, 2020
COVID-19: Antitrust Implications of Dynamic Pricing, Online Third-Party Seller Platforms and Price Gouging
Cooley Alert • April 30, 2020
Automattic Enters Agreement to Acquire Tumblr From Verizon
August 12, 2019
Antitrust Trends in 2019: Enforcement Watch List for the Year to Come
Cooley Alert • January 7, 2019
Arena Pharmaceuticals Enters $1.2 Billion Agreement With United Therapeutics
November 30, 2018
Lightspeed Invests in TripActions and Netskope
November 29, 2018
Agreements Involving Biosimilars Must Be Reported to FTC and DOJ Under New Law
Cooley Alert • October 19, 2018
Mattersight to Sell to NICE
June 4, 2018
Uber Closes SoftBank Investment
February 12, 2018
Patheon Secures $18.5 Million in Attorney Fees Post Procaps Antitrust Victory
August 25, 2017
Airline Fares Antitrust Row Wrongly Axed, Court Told
Law360 • January 6, 2017
Appellate Court Affirms Victory for Patheon in Antitrust Suit with Procaps
January 5, 2017
11th Circ. Nixes Procaps' Bid To Revive $255M Antitrust Suit
Law360 • January 3, 2017
New Antitrust Risks from Introducing New Drugs
By David Burns and Howard Morse • November 28, 2016
Prasco Acquires Rights to Authorized Generic of Adderall XR®
October 17, 2016
Antitrust Claims Nixed In American, Delta, United Fare Row
Law360 • July 25, 2016
Top 10 Antitrust Developments And Trends To Watch This Year
Law360 • January 12, 2016
Top 10 Antitrust Developments and Trends to Watch in 2016
Cooley Alert • January 11, 2016
Back in the Limelight: Innovation as Antitrust Violation
ABA Section of Antitrust Law • December 1, 2015
Patheon Prevails in Antitrust Battle with Procaps
October 30, 2015
Second Circuit Rules that "Product Hopping" May Constitute Unlawful Monopolization; Pharmaceutical Companies are Likely Targets of Future Antitrust Enforcement
Cooley Alert • June 12, 2015
NetScout Systems Receives DOJ Antitrust Clearance for $2.6 Billion Acquisition
April 28, 2015
Auspex Pharma to be Acquired by Teva for $3.5 Billion
March 31, 2015
Spotted: Possible Efficiencies in Competitor Combos (Daily Journal)
March 5, 2015
Ninth Circuit Recognizes Efficiencies May Enhance Competition in Antitrust Challenge to Merger*
Cooley Alert • March 2, 2015
FTC Commencing Major Study of Patent Assertion Entities
Inquiry to Focus on Wireless Industry • November 26, 2013
FTC Expands HSR Reporting Obligations: Targeting Pharmaceutical Licensing Deals
Cooley Alert • November 15, 2013
Cooley Antitrust Team Helps Clear Tesoro for $1.075 Billion Acquisition
June 3, 2013